DK0600544T3 - Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater - Google Patents

Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater

Info

Publication number
DK0600544T3
DK0600544T3 DK93203295T DK93203295T DK0600544T3 DK 0600544 T3 DK0600544 T3 DK 0600544T3 DK 93203295 T DK93203295 T DK 93203295T DK 93203295 T DK93203295 T DK 93203295T DK 0600544 T3 DK0600544 T3 DK 0600544T3
Authority
DK
Denmark
Prior art keywords
lycopene
cells
pharmaceutical preparations
cancer cells
reduce activity
Prior art date
Application number
DK93203295T
Other languages
English (en)
Inventor
Joseph Levy
Yoav Sharoni
Original Assignee
Lycored Natural Prod Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11064278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0600544(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lycored Natural Prod Ind Ltd filed Critical Lycored Natural Prod Ind Ltd
Application granted granted Critical
Publication of DK0600544T3 publication Critical patent/DK0600544T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93203295T 1992-11-30 1993-11-25 Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater DK0600544T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10392092A IL103920A (en) 1992-11-30 1992-11-30 Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof

Publications (1)

Publication Number Publication Date
DK0600544T3 true DK0600544T3 (da) 2002-11-18

Family

ID=11064278

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93203295T DK0600544T3 (da) 1992-11-30 1993-11-25 Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater

Country Status (14)

Country Link
US (1) US5827900A (da)
EP (1) EP0600544B1 (da)
JP (1) JPH06227970A (da)
KR (1) KR100301682B1 (da)
CN (1) CN1142774C (da)
AT (1) ATE225168T1 (da)
AU (1) AU679467B2 (da)
CA (1) CA2109750A1 (da)
DE (1) DE69332350T2 (da)
DK (1) DK0600544T3 (da)
ES (1) ES2181682T3 (da)
IL (1) IL103920A (da)
MX (1) MX9307509A (da)
ZA (1) ZA938791B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262109B1 (en) 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
EP0793491B1 (en) * 1994-12-22 2003-05-02 Henkel Corporation Pharmaceutical compositions comprising lycopene
JP2750281B2 (ja) * 1995-06-15 1998-05-13 睦憲 藤原 高コレステロール血症治療剤
IT1283143B1 (it) * 1996-07-12 1998-04-07 Indena Spa Metodo di estrazione del licopene ed estratti che lo contengono
US20060160702A1 (en) * 1998-02-23 2006-07-20 Etienne Soudant Compositions comprising anti-proliferative agents and use thereof
GB9808796D0 (en) 1998-04-24 1998-06-24 Rowett Research Services Limit Antithrombotic agents
GB9821671D0 (en) 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
IL129442A0 (en) * 1999-04-14 2000-02-29 Lycored Natural Prod Ind Ltd Compounds useful in reducing the level of insulin like growth factor-1 (IGF-1) in blood
US6482447B2 (en) 1999-09-10 2002-11-19 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
IL135335A (en) * 2000-03-29 2013-12-31 Lycored Natural Prod Ind Ltd Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids
US6989161B2 (en) * 2000-06-12 2006-01-24 Access Business Group International Llc Phytonutrient nutritional supplement
IL146449A0 (en) * 2001-11-12 2002-07-25 Lycored Natural Prod Ind Ltd Method and pharmaceutical preparations for reducing the activity of cells
EP1314438A1 (en) * 2001-11-23 2003-05-28 Nutricia N.V. Anti-proliferative composition
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
CA2625433A1 (en) 2005-10-11 2007-04-19 Lycored Ltd. Carotenoid oxidation products as chemopreventive and chemotherapeutic agents
US8569356B2 (en) * 2005-10-25 2013-10-29 University Of Florida Research Foundation, Inc. Cyclin dependent kinase inhibitors
TW200738227A (en) * 2006-04-03 2007-10-16 Panatoz Corp One kind of multi-carotenoids and its administration
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
CN101978986A (zh) * 2010-10-21 2011-02-23 蒋科罡 一种治疗肿瘤的中药制剂及制法
CN101961354A (zh) * 2010-10-21 2011-02-02 蒋科罡 一种配用蜂王浆治疗肿瘤的中药及制法
CN102894421A (zh) * 2011-07-24 2013-01-30 江西食方食坊中药食品有限公司 一种预防前列腺疾病的番杞饮料及其制备方法
CN107049998A (zh) * 2016-09-20 2017-08-18 南华大学附属第二医院 番茄红素顺式异构体在制备卵巢癌治疗药物中的应用
IT201700005649A1 (it) * 2017-01-19 2018-07-19 Associazione Oncologica Milanese Amo La Vita Onlus Uso di derivati di carotenoidi per ridurre la tossicità ed aumentare l’efficacia di trattamenti antitumorali anti-egfr
CN109172552A (zh) * 2018-07-18 2019-01-11 浙江格蕾斯生物科技有限公司 男性前列腺癌植物防治药物及制取方法
KR102220400B1 (ko) * 2019-03-06 2021-02-26 파이룽 머시너리 밀 코., 엘티디. 2개의 노크-오버로 형성된 비트 사이에 조절 가능한 간극을 갖는 횡편기 구조

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509587A (en) * 1975-08-19 1978-05-04 Ajinomoto Kk Anti-tumour composition
FR2558372B1 (fr) * 1984-01-25 1987-08-07 Oreal Composition medicamenteuse pour le traitement de l'acne
US5008295A (en) * 1987-07-30 1991-04-16 Lion Corporation Method inhibiting the growth of cancer cells
ES2073475T3 (es) * 1989-04-21 1995-08-16 Kirin Brewery Secuencias de dna utilizables en la sintesis de carotenoides.
FR2664164A1 (fr) * 1990-07-04 1992-01-10 Texinfine Patrinove Composition dermatologique ou cosmetique.

Also Published As

Publication number Publication date
AU5201493A (en) 1994-06-09
ZA938791B (en) 1994-10-03
EP0600544B1 (en) 2002-10-02
KR940011010A (ko) 1994-06-20
KR100301682B1 (ko) 2001-10-22
US5827900A (en) 1998-10-27
ATE225168T1 (de) 2002-10-15
JPH06227970A (ja) 1994-08-16
DE69332350D1 (de) 2002-11-07
IL103920A0 (en) 1993-04-04
MX9307509A (es) 1997-06-28
DE69332350T2 (de) 2003-06-18
CN1095589A (zh) 1994-11-30
AU679467B2 (en) 1997-07-03
EP0600544A1 (en) 1994-06-08
IL103920A (en) 2000-07-26
ES2181682T3 (es) 2003-03-01
CN1142774C (zh) 2004-03-24
CA2109750A1 (en) 1994-05-31

Similar Documents

Publication Publication Date Title
DK0600544T3 (da) Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater
ZA885192B (en) Pharmaceutical preparations
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ZA937951B (en) Prodrugs,their preparation and use as pharmaceuticals
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
BR8604535A (pt) Composicao inseticida compreendendo mais que um ingrediente ativo
ES2194055T3 (es) Nuevo uso de prostaglandinas.
NO954506D0 (no) Hellbare, topiske formuleringer inneholdende polymert materiale, glycoler og glycerider
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
NO882509D0 (no) Nye pyrazolforbindelser og herbicide preparater inneholdende dem som aktive bestanddeler.
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
ES8105148A1 (es) Un procedimiento para la preparacion de una composicion far-maceutica de quinazolinonas analgesicas
IL76345A0 (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
ES8800139A2 (es) Mejoras introducidas en el objeto de la patente principal por un procedimiento para la preparacion de derivados de urea.
DK123986A (da) 2-chlor-ethyl-phosphonsyre-estere og plantevaekstregulerende midler, der indeholder saadanne som aktive bestanddele
RU93053031A (ru) Способ снижения активности клеток, способ подавления раковых клеток и фармацевтические препараты для снижения активности клеток, способ лечения
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
LV5758A4 (lv) Sastavs aktiva ingredienta kontroletai padevei
ITMI921151A1 (it) Composti terapeuticamente attivi, particolarmente ad attivita' nootropica e procedimento per la loro preparazione
IT1254256B (it) Derivati di idroisochinolina
ITMI910951A0 (it) Composti terapeuticamente attivi, particolarmente ad attivita' nootropica e procedimento per la loro preparazione